GlassScriptPhysician profile
Keith A Sargent
NPI 1952595506
$2,765.33
in general payments reported to CMS, 2019-2025
39 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $195 · 2021: $272 · 2022: $676 · 2023: $533 · 2024: $297 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,105.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $450.40 | 2022-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $440.06 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $228.96 | 2019-2022 | |
| Lilly USA, LLC | $132.80 | 2019-2023 | Mounjaro |
| Novartis Pharmaceuticals Corporation | $126.68 | 2019-2023 | |
| Glaxosmithkline, LLC. | $125.53 | 2022-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Abbvie INC. | $96.20 | 2021-2025 | Vraylar |
| Jazz Pharmaceuticals INC. | $90.81 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $86.73 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $81.01 | 2019-2025 | Breztri |
| Sanofi-Aventis U.S. LLC | $78.14 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $72.46 | 2019 | |
| Harmony Biosciences LLC | $64.45 | 2020-2021 | |
| Eisai INC. | $59.18 | 2020-2024 | |
| Insulet Corporation | $57.08 | 2021-2023 | Omnipod |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $45.50 | 2022-2024 | Gvoke Hypopen |
| Exact Sciences Corporation | $45.09 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Tactile Systems Technology INC | $41.42 | 2022 | |
| Corcept Therapeutics | $40.70 | 2020-2022 | |
| Lundbeck LLC | $31.25 | 2022 | |
| Pfizer INC. | $28.67 | 2019-2022 | |
| Shire North American Group INC | $27.40 | 2019 | |
| Supernus Pharmaceuticals, INC. | $27.29 | 2019 | |
| Janssen Pharmaceuticals, INC | $25.38 | 2019 | |
| Radius Health, INC. | $24.66 | 2025 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.38 | 2024 | Jardiance |
| Biohaven Pharmaceuticals, INC. | $20.51 | 2021 | |
| Boston Scientific Corporation | $20.48 | 2025 | General - Dbs |
| Baxter Healthcare | $18.86 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Biogen, INC. | $17.88 | 2024 | Spinraza |
| Tandem Diabetes Care, INC. | $17.86 | 2021 | |
| Ani Pharmaceuticals, INC. | $17.55 | 2025 | Purified Cortrophin Gel |
| Dexcom, INC. | $16.59 | 2023 | Dexcom G6 Transmitter |
| Mallinckrodt Enterprises LLC | $16.31 | 2019 | |
| Astellas Pharma US INC | $15.14 | 2019 | |
| Phathom Pharmaceuticals, INC. | $14.64 | 2025 | Voquezna |
| Avanir Pharmaceuticals, INC. | $13.76 | 2019 | |
| Sanofi Pasteur INC. | $12.78 | 2019 | |
| Dermira, INC. | $12.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Sargent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.